Navigation Links
BioProcessors Launches SimCell(TM) Services to Meet Increased Customer Demand
Date:9/26/2007

WOBURN, Mass., Sept. 26 /PRNewswire/ -- BioProcessors Corporation, a leading innovator of high-throughput cell culture-based solutions for biopharmaceutical process development, expands its Woburn operations and launches new SimCell Services offering.

"We continue to see strong interest in our SimCell technology," said Jonathan Rennert, President and CEO, BioProcessors Corporation. "The biopharmaceutical industry is accelerating its pace to clinical trials in order to identify successful therapeutic candidates sooner. Expanding our capacity and scope allows the company to respond more quickly and effectively to this key market need."

A second SimCell System was recently installed as part of an expanded laboratory and training wing at BioProcessors' Woburn facility. "Two high- throughput Robotic Systems, along with supporting analytical instrumentation and a new multi-media customer training center, provide our new team of cell culture specialists with much more comprehensive applications development and training capabilities," added Rennert. "We are now positioned to expand customer access to SimCell technology through the introduction of our new SimCell Services."

SimCell Services are customized service offerings tailored to meet specific cell culture application requirements of BioProcessors' clients. They provide access to SimCell technology through a hosted cell culture development project, which can range in scope from a simple screening experiment to more comprehensive production clone selection, clone stability, media optimization, or process development experiments. SimCell Services help clients gain better insight into their bioprocesses and reduce development risk by enabling the design of robust, optimized bioprocesses, faster and more efficiently.

About BioProcessors Corporation

BioProcessors Corporation is a developer and provider of micro-engineered solutions for cell culture-based upstream bioprocess development. The Company's SimCell technology provides the capability to perform high throughput cell culture experiments for the development and optimization of biopharmaceutical manufacturing processes. The high throughput capability of the system enables execution of full and fractional factorial statistical experiments at a fraction of the time and cost associated with conventional scale-down technologies. The result is greater insight and reduced risk for bioprocess development decision making.

For more information on BioProcessors Corporation, contact Eric Denoyer, Marketing Director, BioProcessors Corporation +1 781-305-8867, e.denoyer@bioprocessors.com, or visit http://www.bioprocessors.com.


'/>"/>
SOURCE BioProcessors Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
8. Pfizer Launches Viagra For Lung Disease In UK
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CHAPEL HILL, N.C. , June 24, 2016 ... in healthcare decisions and regulators/payers have placed more ... this new environment, patient support programs in the ... support for patients, medications. Consequently, pharmaceutical companies are ... to ensure they are providing products and services ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology: